Next Article in Journal
Eyeglasses Lens Contour Extraction from Facial Images Using an Efficient Shape Description
Next Article in Special Issue
Biostable ssDNA Aptamers Specific for Hodgkin Lymphoma
Previous Article in Journal
On Using Maximum a Posteriori Probability Based on a Bayesian Model for Oscillometric Blood Pressure Estimation
Previous Article in Special Issue
Development of a Multiplex Sandwich Aptamer Microarray for the Detection of VEGF165 and Thrombin
Sensors 2013, 13(10), 13624-13637; doi:10.3390/s131013624
Review

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation

1,* , 1
, 1
, 1
, 1
, 1
, 2
, 3
, 4
, 5
, 6
, 7
, 8
 and 1,*
Received: 7 August 2013; in revised form: 24 September 2013 / Accepted: 27 September 2013 / Published: 10 October 2013
(This article belongs to the Special Issue Aptasensors)
View Full-Text   |   Download PDF [449 KB, uploaded 21 June 2014]   |   Browse Figures
Abstract: Aptamers, and the selection process known as Systematic Evolution of Ligands by Exponential Enrichment (SELEX) used to generate them, were first described more than twenty years ago. Since then, there have been numerous modifications to the selection procedures. This review discusses the use of modified bases as a means of enhancing serum stability and producing effective therapeutic tools, as well as functionalising these nucleic acids to be used as potential diagnostic agents.
Keywords: aptamer; SELEX; cancer; diagnostics; locked nucleic acid; unlocked nucleic acid aptamer; SELEX; cancer; diagnostics; locked nucleic acid; unlocked nucleic acid
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Shigdar, S.; Macdonald, J.; O'Connor, M.; Wang, T.; Xiang, D.; Al.Shamaileh, H.; Qiao, L.; Wei, M.; Zhou, S.-F.; Zhu, Y.; Kong, L.; Bhattacharya, S.; Li, C.; Duan, W. Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation. Sensors 2013, 13, 13624-13637.

AMA Style

Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al.Shamaileh H, Qiao L, Wei M, Zhou S-F, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W. Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation. Sensors. 2013; 13(10):13624-13637.

Chicago/Turabian Style

Shigdar, Sarah; Macdonald, Joanna; O'Connor, Michael; Wang, Tao; Xiang, Dongxi; Al.Shamaileh, Hadi; Qiao, Liang; Wei, Ming; Zhou, Shu-Feng; Zhu, Yimin; Kong, Lingxue; Bhattacharya, Santanu; Li, ChunGuang; Duan, Wei. 2013. "Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation." Sensors 13, no. 10: 13624-13637.


Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert